GOOGL
40
-5
CL
58
2
WEC
53
-2
A
43
2
ES
34
3
PVH
62
5
WBA
48
4
AXP
71
2
FTI
81
5
GS
75
2
TDC
80
4
LRCX
43
-2
FSLR
54
7
BBY
46
10
BF.B
33
2
BK
74
2
AMG
54
2
SO
53
-4
SYY
53
4
SIG
52
3
GOOGL
40
-5
CL
58
2
WEC
53
-2
A
43
2
ES
34
3
PVH
62
5
WBA
48
4
AXP
71
2
FTI
81
5
GS
75
2
TDC
80
4
LRCX
43
-2
FSLR
54
7
BBY
46
10
BF.B
33
2
BK
74
2
AMG
54
2
SO
53
-4
SYY
53
4
SIG
52
3
Financhill
Back

PROCEPT BioRobotics Vs. Perspective Therapeutics Industry Stock Comparison

Sell
43

PRCT
PROCEPT BioRobotics

Last Price:
93.66
Seasonality Move:
-3.87%
Sell
30

CATX
Perspective Therapeutics

Last Price:
3.49
Seasonality Move:
34.33%
Sell
43
PROCEPT BioRobotics (PRCT) is a Sell

Is PROCEPT BioRobotics a Buy, Sell or Hold?

  • The current PROCEPT BioRobotics [PRCT] share price is $93.60. The Score for PRCT is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • PRCT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
30
Perspective Therapeutics (CATX) is a Sell

Is Perspective Therapeutics a Buy, Sell or Hold?

  • The current Perspective Therapeutics [CATX] share price is $3.47. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
  • CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

PRCT Stock Price Chart

What is PROCEPT BioRobotics's stock price today?

  • The PROCEPT BioRobotics share price today is $93.60
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PRCT is experiencing slight selling pressure.

CATX Stock Price Chart

What is Perspective Therapeutics's stock price today?

  • The Perspective Therapeutics share price today is $3.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing buying pressure, which is a positive indicator for future bullish movement.

PRCT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 3.46 Buy
Relative Strength Index (14 RSI): 57.39 Buy
Chaikin Money Flow: -134868 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (77.79 - 99.31) Buy
Bollinger Bands (100): (64.8 - 86.96) Buy

CATX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.06 Sell
Relative Strength Index (14 RSI): 14.31 Sell
Chaikin Money Flow: 5909257 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (7.39 - 12.93) Sell
Bollinger Bands (100): (10.25 - 14.79) Sell

PRCT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 91.55 Buy
20-day SMA: 93.72 Sell
50-day SMA: 82.41 Buy
200-day SMA: 65.91 Buy
8-day EMA: 92.87 Buy
20-day EMA: 90.37 Buy
50-day EMA: 84.09 Buy
200-day EMA: 68 Buy

CATX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 6.64 Sell
20-day SMA: 9.7 Sell
50-day SMA: 11.58 Sell
200-day SMA: 12.72 Sell
8-day EMA: 6.25 Sell
20-day EMA: 8.74 Sell
50-day EMA: 10.88 Sell
200-day EMA: 11.36 Sell

PROCEPT BioRobotics Earnings Growth & PRCT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.41 per share, and an increase next year of $0.37 per share.

Perspective Therapeutics Earnings Growth & CATX Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.79 per share, and a decrease next year of $0.49 per share.

PROCEPT BioRobotics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Perspective Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):